CIK 0001385818 · Non-accelerated filer<br>Smaller reporting company
AYTU BIOPHARMA, INC
Sign in to watch- Ticker
- AYTU
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Jun 30
- Incorporated
- DE
- Entity type
- operating
- EIN
- 470883144
- Phone
- (720) 437-6580
- Business address
- 7900 E. UNION AVENUE, SUITE 920, DENVER, CO, 80237
- Former names
- AYTU BIOSCIENCE, INC, Rosewind CORP
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-06-30 | PYSZCZYMUKA GREG Chief Commercial Officer | Option exercise · Restricted Stock Units | −208 | 626 | ||
| 2024-06-14 | Nantahala Capital Management, LLC 10% owner | Option exercise · Tranche B Warrant | −815,217 | 0 | ||
| 2024-06-14 | Nantahala Capital Management, LLC 10% owner | Option exercise · Exchange Warrants | +815,217 | 815,217 | ||
| 2024-03-31 | PYSZCZYMUKA GREG Chief Commercial Officer | Option exercise | +208 | 22,768 | ||
| 2024-03-31 | PYSZCZYMUKA GREG Chief Commercial Officer | Option exercise · Restricted Stock Units | −208 | 834 | ||
| 2023-12-31 | PYSZCZYMUKA GREG Chief Commercial Officer | Option exercise | +209 | 22,560 | ||
| 2023-12-31 | PYSZCZYMUKA GREG Chief Commercial Officer | Option exercise · Restricted Stock Units | −209 | 1,042 | ||
| 2023-09-30 | PYSZCZYMUKA GREG Chief Commercial Officer | Option exercise | +208 | 22,351 | ||
| 2023-09-30 | PYSZCZYMUKA GREG Chief Commercial Officer | Option exercise · Restricted Stock Units | −208 | 1,251 | ||
| 2023-08-16 | JAIN ABHINAV Director | Grant or award | +6,500 | 8,000 | ||
| 2023-08-11 | LIU VIVIAN H Director | Grant or award | +1,500 | 8,325 | ||
| 2023-08-11 | Disbrow Jarrett Chief Business Officer | Grant or award · Employee Stock Option (Right to Buy) | +7,000 | 7,000 | ||
| 2023-08-11 | JAIN ABHINAV Director | Grant or award | +1,500 | 1,500 | ||
| 2023-08-11 | LIU VIVIAN H Director | Grant or award | +1,500 | 1,841 | ||
| 2023-08-11 | Donofrio John Jr. Director | Grant or award | +1,500 | 2,262 | ||
| 2023-08-11 | DOCKERY CARL Director | Grant or award | +1,500 | 8,940 | ||
| 2023-08-11 | Disbrow Joshua R. Chief Executive Officer | Grant or award · Employee Stock Option (Right to Buy) | +35,000 | 35,000 | ||
| 2023-08-11 | BROOKE CHRISTOPHER Chief Operating Officer | Grant or award · Employee Stock Option (Right to Buy) | +7,000 | 7,000 | ||
| 2023-08-11 | Oki Mark K Chief Financial Officer | Grant or award · Employee Stock Option (Right to Buy) | +13,000 | 13,000 | ||
| 2023-08-11 | PYSZCZYMUKA GREG Chief Commercial Officer | Grant or award · Employee Stock Option (Right to Buy) | +7,000 | 7,000 |
Page 3 of 15 · 300 trades